계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
Mimetas
company
About
MIMETAS develops organ-on-a-chip tissue- and disease models for better, more reliable, and tailored medicines.
- 101 - 250
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $20.50M
- Industries
- 3D Technology,Biotechnology,Health Care,Information Technology
- Founded date
- Jan 1, 2013
- Number Of Employee
- 101 - 250
- Operating Status
- Active
MIMETAS develops predictive Organ-on-a-Chip cell culture models for better, more reliable and tailored medicines. A significant gap exist between the predictive value of various in vitro and animal screening models and a patient. MIMETAS fills this gap with its OrganoPlates featuring organotypic screening models that have an improved predictability and can be screened at a high throughput.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$25.70M
Mimetas has raised a total of
$25.70M
in funding over 2 rounds. Their latest funding was raised on
Apr 11, 2018 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Apr 11, 2018 | Series B | $20.50M | 2 | — | — | Detail |
| Oct 8, 2014 | Series A | $5.20M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
3
Mimetas is funded by 3 investors.
Cathay Venture
and European Life Sciences Growth Fund
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series B |
|
|
— | Series B |
Zeeuws Investerings Fonds
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
